These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 18364097

  • 1. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
    Toal M, Chaddha V, Windrim R, Kingdom J.
    J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
    [Abstract] [Full Text] [Related]

  • 2. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler.
    Hershkovitz R, de Swiet M, Kingdom J.
    Hypertens Pregnancy; 2005 Mar; 24(3):273-80. PubMed ID: 16263599
    [Abstract] [Full Text] [Related]

  • 3. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A, Wilson RD, SOCIETY OF OBSTETRICIANS AND GYNAECOLOGISTS OF CANADA GENETICS COMMITTEE.
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [Abstract] [Full Text] [Related]

  • 4. Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening.
    Filippi E, Staughton J, Peregrine E, Jones P, Huttly W, Peebles DM, Pandya P, David AL.
    Ultrasound Obstet Gynecol; 2011 May; 37(5):520-7. PubMed ID: 21520313
    [Abstract] [Full Text] [Related]

  • 5. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
    Audibert F, Benchimol Y, Benattar C, Champagne C, Frydman R.
    Fetal Diagn Ther; 2005 May; 20(1):48-53. PubMed ID: 15608460
    [Abstract] [Full Text] [Related]

  • 6. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin.
    Alkazaleh F, Chaddha V, Viero S, Malik A, Anastasiades C, Sroka H, Chitayat D, Toi A, Windrim RC, Kingdom JC.
    Am J Obstet Gynecol; 2006 Mar; 194(3):821-7. PubMed ID: 16522419
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS, Bernstein IM, Capeless EL.
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [Abstract] [Full Text] [Related]

  • 9. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
    Karsidag AY, Buyukbayrak EE, Kars B, Suyugul U, Unal O, Turan MC.
    J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
    Tancrède S, Bujold E, Giguère Y, Renald MH, Girouard J, Forest JC.
    J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
    [Abstract] [Full Text] [Related]

  • 12. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
    Jauniaux E, Gulbis B, Tunkel S, Ramsay B, Campbell S, Meuris S.
    Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
    [Abstract] [Full Text] [Related]

  • 13. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.
    Elsandabesee D, Srinivas M, Kodakkattil S.
    J Obstet Gynaecol; 2006 Feb; 26(2):115-7. PubMed ID: 16483965
    [Abstract] [Full Text] [Related]

  • 14. Screening for placental insufficiency in high-risk pregnancies: is earlier better?
    Costa SL, Proctor L, Dodd JM, Toal M, Okun N, Johnson JA, Windrim R, Kingdom JC.
    Placenta; 2008 Dec; 29(12):1034-40. PubMed ID: 18930542
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
    Dimitrova V, Chernev T, Vragaleva S, Slŭncheva B, Mikhaĭlova E, Kremenski I, Simeonov E.
    Akush Ginekol (Sofiia); 2002 Dec; 41(6):3-12. PubMed ID: 12577497
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictive Value of Second-Trimester Biomarkers and Maternal Features for Adverse Pregnancy Outcomes.
    Yefet E, Kuzmin O, Schwartz N, Basson F, Nachum Z.
    Fetal Diagn Ther; 2017 Dec; 42(4):285-293. PubMed ID: 28395283
    [Abstract] [Full Text] [Related]

  • 19. Mid-trimester uterine artery Doppler screening as a predictor of adverse pregnancy outcome in high-risk women.
    Coleman MA, McCowan LM, North RA.
    Ultrasound Obstet Gynecol; 2000 Jan; 15(1):7-12. PubMed ID: 10776006
    [Abstract] [Full Text] [Related]

  • 20. Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies.
    Schwarze A, Nelles I, Krapp M, Friedrich M, Schmidt W, Diedrich K, Axt-Fliedner R.
    Arch Gynecol Obstet; 2005 Jan; 271(1):46-52. PubMed ID: 15185101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.